Insight Molecular Diagnostics Inc. (IMDX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) 
$
4. 74
+0.03
+0.6369%
$
- Market Cap
- P/E Ratio
- Div Yield
39,100 Volume
- Eps
$ 4.71
Previous Close 
Want to track IMDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Insight Molecular Diagnostics Inc. (IMDX) Statistics
Valuation metrics
Market Cap -
Enterprise value 102.1M
Trailing P/E (ttm) -3.13
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 65.28
Price/Book (mrq) -15.3
Enterprise Value/Revenue 52.38
Enterprise Value/EBITDA -2.25
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 39.1K
Average volume (90 days) 406.81K
Price summary
52-Week low 2.33
52-Week high 8.51
Beta -
50-Day moving average 5.46
200-Day moving average 5.31
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 25 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -24.55%
Operating margin -21.12%
Operational effectiveness
Return on assets -1.18%
Return on equity 3.81%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.82
Total debt (mrq) -
Total Debt/Equity (mrq) -0.29
Current ratio (mrq) 2.54%
Book value per share (mrq) -0.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
